BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 24, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2021
View Archived Issues
Shire Human Genetic Therapies describes IDS gene therapy
Read More
New influenza A virus vaccine synthesized at the University of Gdansk
Read More
Pentadefenin hydrogel developed for treating vaginitis
Read More
GS-441524 is an effective antiviral against African swine fever virus in vitro
Read More
Results of phase I trial of CRAd-S-pk7 oncolytic adenovirus delivered by neural stem cells in glioma
Read More
Possible target LGALS3BP binds to SARS-CoV-2 spike glycoprotein
Read More
Sinovent patents CDK7/cyclin H inhibitors
Read More
New protein O-GlcNAcase inhibitors discovered at Janssen Pharmaceutica
Read More
Phase Ib extension data for belapectin plus Keytruda in melanoma and head and neck cancer
Read More
FDA places clinical hold on phase I/II study of SIG-001 in hemophilia A
Read More
Eli Lilly initiates phase I study of LY-3819469
Read More
Enrollment ongoing first-in-human study of PBI-200
Read More
ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults
Read More
Ranitidine bismuth citrate shows potency for treating SARS-CoV-2 infection
Read More
Rare coding variant increases risk of Y chromosome loss, diabetes
Read More
Dosing begins in phase I study in China of IBI-323 for advanced malignant tumors
Read More
FDA clears initiation of phase II trial of pyrilutamide in androgenetic alopecia
Read More
Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer
Read More
NTLA-2001 decreases serum TTR protein concentrations through targeted knockout of TTR
Read More
Ampligen to be studied in phase IIa human challenge trial as intranasal antiviral therapy
Read More
Octenidine shows potential for treating multidrug-resistant Candida infection
Read More
Preliminary phase II data with COVID-19 vaccine candidate GRAd-COV2 support progression
Read More
Inotrem gains clearance in France and Belgium to advance nangibotide for COVID-19
Read More
Enterome begins dosing in phase I/II study of EO-2463 in indolent NHL
Read More
Amniotics to advance PulmoStem into clinic next year
Read More